KLF5 and cancer: However, patients with copy number gains in KLF5, ZFHX3 and CDH1 had reduced cancer-specific survival, compared to patients without CNV in these genes ZFHX3 and CDH1, respectively (pairwise p ≤ 0.044; Figure 2).